Annual CFF
$11.65 M
-$3.43 M-22.75%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual cash flow from financing activities is $11.65 million, with the most recent change of -$3.43 million (-22.75%) on December 31, 2024.
- During the last 3 years, NVCT annual CFF has fallen by -$3.59 million (-23.56%).
- NVCT annual CFF is now -58.09% below its all-time high of $27.81 million, reached on December 31, 2022.
Performance
NVCT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
December 31, 2024
Summary
- NVCT quarterly cash flow from financing activities is not available.
Performance
NVCT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
December 31, 2024
Summary
- NVCT TTM cash flow from financing activities is not available.
Performance
NVCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVCT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.8% | - | - |
| 3 y3 years | -23.6% | - | - |
| 5 y5 years | - | - | - |
NVCT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.1% | at low | ||||
| 5 y | 5-year | -58.1% | at low | ||||
| alltime | all time | -58.1% | at low |
Nuvectis Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $11.65 M(-22.8%) | - | - |
| Sep 2024 | - | $1.46 M(-12.9%) | $8.74 M(+9.4%) |
| Jun 2024 | - | $1.67 M(-64.4%) | $7.99 M(-59.1%) |
| Mar 2024 | - | $4.70 M(+412.1%) | $19.53 M(+29.5%) |
| Dec 2023 | $15.09 M(-45.7%) | $917.00 K(+30.4%) | $15.09 M(+7.5%) |
| Sep 2023 | - | $703.00 K(-94.7%) | $14.04 M(-49.6%) |
| Jun 2023 | - | $13.21 M(+5144.0%) | $27.83 M(+98.3%) |
| Mar 2023 | - | $252.00 K(-292.4%) | $14.04 M(-49.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $27.81 M(+82.4%) | -$131.00 K(-100.9%) | $27.81 M(-0.5%) |
| Sep 2022 | - | $14.49 M(-2607.3%) | $27.94 M(+59.9%) |
| Jun 2022 | - | -$578.00 K(-104.1%) | $17.47 M(-40.3%) |
| Mar 2022 | - | $14.03 M(>+9900.0%) | $29.27 M(+92.0%) |
| Dec 2021 | $15.25 M | $0.00(-100.0%) | $15.25 M(0.0%) |
| Sep 2021 | - | $4.02 M(-64.2%) | $15.25 M(+35.8%) |
| Jun 2021 | - | $11.22 M(>+9900.0%) | $11.22 M(>+9900.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
FAQ
- What is Nuvectis Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Nuvectis Pharma?
- What is Nuvectis Pharma annual CFF year-on-year change?
- What is the all time high quarterly CFF for Nuvectis Pharma?
- What is the all time high TTM CFF for Nuvectis Pharma?
What is Nuvectis Pharma annual cash flow from financing activities?
The current annual CFF of NVCT is $11.65 M
What is the all time high annual CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high annual cash flow from financing activities is $27.81 M
What is Nuvectis Pharma annual CFF year-on-year change?
Over the past year, NVCT annual cash flow from financing activities has changed by -$3.43 M (-22.75%)
What is the all time high quarterly CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly cash flow from financing activities is $14.49 M
What is the all time high TTM CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM cash flow from financing activities is $29.27 M